Evidence map›Paper›PMID 35886938›Full record

ArticleInternational journal of molecular sciences2022

A Panel of Eight miRNAs Is Deregulated in HTLV-2 Infected PBMCs and BJABGu Cell Line.

Elisabetta Pilotti, Attilio Cannata, Giacomo Magnani, Fabio Bignami, Andrea Corsi, Maria Teresa Valenti, Mariam Shallak, Greta Forlani, Maria Grazia Romanelli

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Elisabetta PilottiDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.ORCID 0000-0002-2061-8276
Attilio CannataL.C. Laboratori Campisi s.r.l., 96012 Avola, Italy.
Giacomo MagnaniUnit of Infectious Diseases, Azienda USL-IRCCS, 42121 Reggio Emilia, Italy.
Fabio BignamiDepartment of Clinical Sciences, University of Milano, 20121 Milano, Italy.
Andrea CorsiDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.
Maria Teresa ValentiDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.ORCID 0000-0003-1166-8033
Mariam ShallakLaboratory of General Pathology and Immunology "Giovanna Tosi", Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.
Greta ForlaniLaboratory of General Pathology and Immunology "Giovanna Tosi", Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.ORCID 0000-0003-1987-7761
Maria Grazia RomanelliDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37124 Verona, Italy.ORCID 0000-0002-7360-1195
University of Verona · ITUniversity of Insubria · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 being retroviruses closely related at a genomic level, HTLV-2 differs from HTLV-1 in terms of pathogenicity in both single infection and coinfection contexts. Moreover, the HTLV-2 association with clinical outcomes is still debated and several mechanisms underlying HTLV-2 infection remain unexplored as well. Cellular miRNAs are key factors in the post-transcriptional regulation of gene expression and they are known to be potential targets for several pathogens to control the host microenvironment and, in particular, escape immune responses. Here, we identified a HTLV-2-related signature of eight miRNAs (miR-125a-3p, miR-381-3p, miR-502-5p, miR-708-5p, miR-548d-5p, miR-548c-5p, miR-1-3p, and miR-511-5p) in both HTLV-2 infected PBMC and BJABGu cell lines. Altered miRNA expression patterns were correlated with the impairment of Th cell differentiation and signaling pathways driven by cytokines and transcriptional factors such as the Runt-related transcription factor (RUNX) family members. Specifically, we demonstrated that the RUNX2 protein was significantly more expressed in the presence of Tax-2 compared with Tax-1 in an in vitro cell model. To the best of our knowledge, these data represent the first contribution to elucidating the HTLV-2 mediated alteration of host cell miRNA profiles that may impact on HTLV-2 replication and persistent infection.

Indexed as

Human T-lymphotropic virus 1MicroRNAsCell LineHumansHuman T-lymphotropic virus 2Leukocytes, MononuclearTranscription FactorsMicroRNAsMIRN381 microRNA, humanTranscription Factorscell signaling pathwayshost-virus interactionsHTLV-2miRNARUNXTax

Identifiers

PMID35886938
PMCPMC9320395
OpenAlexW4284961599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.